Span Divergent Quarterly Results for Trading Insights
SDL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QSept 2025
Span Divergent Quarterly Results Key Highlights
- Revenue of ₹8 Cr in Sept 2025 (+700.0% vs Mar 2025, +166.7% vs Sept 2024)
- Operating Margin of -1.0% in Sept 2025 (+197.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.34 in Sept 2025 (+81.8% vs Mar 2025)
Span Divergent Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 8 | 1 | 2 | 3 | 4 | 700.0% | 166.7% |
| Net Profit (₹ Cr) | 0 | -1 | 0 | 0 | 1 | - | - |
| EBITDA (₹ Cr) | 0 | -1 | 0 | 0 | 1 | - | - |
| EPS (₹) | -0.34 | -1.87 | -0.31 | 0.09 | 1.62 | - | - |
| Operating Margin (%) | -1.0% | -198.0% | -81.0% | 5.0% | -2.0% | - | - |
Span Divergent Share Price Trend Around Quarterly Results
Visualize Span Divergent's 1-year price movement across quarterly results — ideal for logging trades in Span Divergent share price
chart using Tickjournal. All values in ₹.
Related Pages for Span Divergent
Additional stock information and data for SDL
Revenue Trend (₹ Cr)
Sept 2024
3
Jun 2025
2
Mar 2025
1
Sept 2025
8
Net Profit Trend (₹ Cr)
Sept 2024
0
Jun 2025
0
Mar 2025
-1
Sept 2025
0
Operating Margin Trend (%)
Sept 2024
5.0%
Jun 2025
-81.0%
Mar 2025
-198.0%
Sept 2025
-1.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Span Divergent quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.7 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6600.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4026.4 | 3,219 | 591 | +11.3% | - | 18.4% | 229.6 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1460.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1206.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores